Skip to main content
Clinical Trials/JPRN-UMIN000041822
JPRN-UMIN000041822
Completed
N/A

Prospective study analyzed the association between efficacy and adverse events by Atezolizumab immunotherapy and diversity or species of fecal microbiota in advanced /reccurent non-small cell lung cancer patients - Prospective study analyzed the association between efficacy and adverse events by Atezolizumab immunotherapy and diversity or species of fecal microbiota in advanced /reccurent non-small cell lung cancer patients

ational Hospital Organization Kyushu Medical Center, Clinical Research Institute0 sites60 target enrollmentOctober 1, 2020

Overview

Phase
N/A
Intervention
Not specified
Conditions
advanced/reccurent non-small cell lung cancer patients
Sponsor
ational Hospital Organization Kyushu Medical Center, Clinical Research Institute
Enrollment
60
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 1, 2020
End Date
September 30, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
ational Hospital Organization Kyushu Medical Center, Clinical Research Institute

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\) Inadequate cases judged by doctors

Outcomes

Primary Outcomes

Not specified

Similar Trials